Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Affimed Files For Common Stock Offering Of Up To $100M

-SEC Filing

byMichael Horton

March 23, 2023

1 minute read

-SEC Filing

Hepion’s CRV431 Shows Encouraging Safety Profile In Drug-Drug Interaction Study

By Vandana Singh

Today, 12:12 PM

Hepion Pharmaceuticals Inc (NASDAQ:HEPA) has announced results from a Drug-Drug Interaction (DDI) study with its lead drug candidate, CRV431. CRV431 targets…

HEPA

Jeffs’ Brands Acquires UK Pest Control Company For $2.5M Cash

By Shivani Kumaresan

Today, 12:12 PM

Jeffs’ Brands Ltd (NASDAQ:JFBR) has entered into a non-binding term sheet with a company incorporated in England engaged in the sale of…

JFBR

Wedbush Downgrades Impel Pharmaceuticals to Neutral, Lowers Price Target to $5

By Benzinga Newsdesk

Today, 12:12 PM

Wedbush analyst Laura Chico downgrades Impel Pharmaceuticals (NASDAQ:IMPL) from Outperform to Neutral and lowers the price target from $24 to $5.

IMPL

Truist Securities Maintains Hold on Ollie’s Bargain Outlet, Lowers Price Target to $38

By Benzinga Newsdesk

Today, 12:12 PM

Truist Securities analyst Scot Ciccarelli maintains Ollie's Bargain Outlet (NASDAQ:OLLI) with a Hold and lowers the price target from $41 to $38.

OLLI

Affimed Files For Common Stock Offering Of Up To $100M

Related Posts

Hepion’s CRV431 Shows Encouraging Safety Profile In Drug-Drug Interaction Study

Jeffs’ Brands Acquires UK Pest Control Company For $2.5M Cash

Wedbush Downgrades Impel Pharmaceuticals to Neutral, Lowers Price Target to $5

Truist Securities Maintains Hold on Ollie’s Bargain Outlet, Lowers Price Target to $38